JP2012532859A5 - - Google Patents

Download PDF

Info

Publication number
JP2012532859A5
JP2012532859A5 JP2012519080A JP2012519080A JP2012532859A5 JP 2012532859 A5 JP2012532859 A5 JP 2012532859A5 JP 2012519080 A JP2012519080 A JP 2012519080A JP 2012519080 A JP2012519080 A JP 2012519080A JP 2012532859 A5 JP2012532859 A5 JP 2012532859A5
Authority
JP
Japan
Prior art keywords
cells
fibroblasts
regulatory
stem cells
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012519080A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012532859A (ja
JP5892931B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2010/001968 external-priority patent/WO2011004264A1/en
Publication of JP2012532859A publication Critical patent/JP2012532859A/ja
Publication of JP2012532859A5 publication Critical patent/JP2012532859A5/ja
Application granted granted Critical
Publication of JP5892931B2 publication Critical patent/JP5892931B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012519080A 2009-07-09 2010-07-09 細胞治療において使用するための方法および組成物 Active JP5892931B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22427509P 2009-07-09 2009-07-09
US61/224,275 2009-07-09
PCT/IB2010/001968 WO2011004264A1 (en) 2009-07-09 2010-07-09 Methods and compositions for use in cellular therapies

Publications (3)

Publication Number Publication Date
JP2012532859A JP2012532859A (ja) 2012-12-20
JP2012532859A5 true JP2012532859A5 (cg-RX-API-DMAC7.html) 2013-08-15
JP5892931B2 JP5892931B2 (ja) 2016-03-23

Family

ID=42782196

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012519080A Active JP5892931B2 (ja) 2009-07-09 2010-07-09 細胞治療において使用するための方法および組成物

Country Status (19)

Country Link
US (1) US8679834B2 (cg-RX-API-DMAC7.html)
EP (2) EP2451943B1 (cg-RX-API-DMAC7.html)
JP (1) JP5892931B2 (cg-RX-API-DMAC7.html)
KR (1) KR101788885B1 (cg-RX-API-DMAC7.html)
CN (2) CN107007626A (cg-RX-API-DMAC7.html)
AU (1) AU2010269962B2 (cg-RX-API-DMAC7.html)
BR (1) BR112012000534A2 (cg-RX-API-DMAC7.html)
CA (1) CA2767300C (cg-RX-API-DMAC7.html)
DK (1) DK2451943T3 (cg-RX-API-DMAC7.html)
ES (1) ES2479542T3 (cg-RX-API-DMAC7.html)
HU (1) HUE031921T2 (cg-RX-API-DMAC7.html)
IL (1) IL217377A (cg-RX-API-DMAC7.html)
MX (1) MX359639B (cg-RX-API-DMAC7.html)
NZ (1) NZ597975A (cg-RX-API-DMAC7.html)
PL (1) PL2451943T3 (cg-RX-API-DMAC7.html)
PT (1) PT2451943T (cg-RX-API-DMAC7.html)
RU (1) RU2610427C2 (cg-RX-API-DMAC7.html)
SG (2) SG177582A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011004264A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2589311T5 (es) 2005-09-23 2020-02-14 Tigenix S A U Poblaciones de células que tienen actividad inmunorreguladora, método de aislamiento y usos
US11090363B2 (en) 2009-07-10 2021-08-17 University of Pittsburgh—of the Commonwealth System of Higher Education Vasoactive intestinal peptide release from microparticles
US8846098B2 (en) 2009-07-10 2014-09-30 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Artificial cell constructs for cellular manipulation
EP2663316A2 (en) * 2011-01-12 2013-11-20 TiGenix, S.A.U. Adipose-derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
CA2857545A1 (en) 2011-11-30 2013-06-06 Advanced Cell Technology, Inc. Mesenchymal stromal cells and uses related thereto
US8961956B2 (en) 2011-11-30 2015-02-24 Ocata Therapeutics, Inc. Mesenchymal stromal cells and uses related thereto
EP2833896A2 (en) * 2012-03-30 2015-02-11 University Of Southern California Compositions and treatment methods for mesenchymal stem cell-induced immunoregulation
WO2014011407A2 (en) 2012-07-12 2014-01-16 Imstem Biotechnology, Inc. Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
US10258652B2 (en) 2014-12-18 2019-04-16 Pluristem Ltd. Methods and compositions for treating and preventing muscle wasting disorders
WO2016107563A1 (zh) * 2014-12-29 2016-07-07 西比曼生物科技(上海)有限公司 一种用于治疗上呼吸道疾病的脂肪间充质祖细胞复合物
IL294058A (en) 2015-03-23 2022-08-01 Pluristem Ltd Use of adherent stromal cells for enhancing hematopoiesis in a subject in need thereof
AU2017220148A1 (en) 2016-02-18 2018-07-19 Pluristem Ltd. Methods and compositions for treating cancers and neoplasms
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
US12161688B2 (en) 2016-06-30 2024-12-10 Mapi Pharma Ltd Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells
AU2017414803B2 (en) 2017-05-15 2025-02-13 Mapi Pharma Ltd. Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
WO2018211498A1 (en) 2017-05-15 2018-11-22 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with adipose-derived stem cells
CN107281469A (zh) * 2017-07-17 2017-10-24 广东颜值科技有限公司 一种细胞组合物及其制备方法和应用
CN107349419A (zh) * 2017-07-17 2017-11-17 广东颜值科技有限公司 一种细胞组合物及其制备方法和应用
US12268714B2 (en) 2018-09-14 2025-04-08 Luca Science Inc. Transplantation of mitochondria into lymphoid organ and composition therefor
JP2022527455A (ja) * 2019-03-19 2022-06-02 フィジーン、エルエルシー 活性化線維芽細胞及びそのエキソソーム誘導体を用いた慢性閉塞性肺疾患及び肺変性の治療
WO2020243504A1 (en) * 2019-05-31 2020-12-03 Figene, Llc Concurrent activation of regenerative and tolerogenic processes by fibroblast-based compositions for the treatment of multiple sclerosis
US20240000850A1 (en) * 2020-04-08 2024-01-04 Figene, Llc Methods and compositions for allergy and asthma treatment using fibroblasts

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60334474D1 (de) * 2002-07-12 2010-11-18 Univ Johns Hopkins Reagenzien und verfahren zum eingriff in einzigartige klonotype lymphozyten-rezeptoren
CN1738619B (zh) * 2002-12-06 2012-04-18 西北生物治疗药物公司 给予体外部分成熟的树突细胞治疗肿瘤的制药用途
ES2589311T5 (es) 2005-09-23 2020-02-14 Tigenix S A U Poblaciones de células que tienen actividad inmunorreguladora, método de aislamiento y usos
US8241621B2 (en) * 2006-12-18 2012-08-14 Medistem Laboratories Stem cell mediated treg activation/expansion for therapeutic immune modulation
AU2008287063B2 (en) * 2007-08-09 2013-10-24 Genzyme Corporation Method of treating autoimmune disease with mesenchymal stem cells
JPWO2009031606A1 (ja) * 2007-09-07 2010-12-16 日本ケミカルリサーチ株式会社 関節炎治療及び予防剤
EP2279246A4 (en) * 2008-05-02 2012-03-28 Massachusetts Inst Technology METHOD AND COMPOSITIONS FOR MODULATING IMMUNOLOGICAL TOLERANCE
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells

Similar Documents

Publication Publication Date Title
JP2012532859A5 (cg-RX-API-DMAC7.html)
RU2012104529A (ru) Способы и композиции для применения в клеточной терапии
Julier et al. Promoting tissue regeneration by modulating the immune system
MX2012002082A (es) Terapia de acetato de glatiramero de baja frecuencia.
ES2479544T1 (es) Células madre mesenquimales derivadas de tejido adiposo para administración intralinfática en enfermedades autoimmunes e inflamatorias
JP2014502628A5 (cg-RX-API-DMAC7.html)
EP3190186A3 (en) Expression of mirnas in placental tissue
SG10201903512SA (en) Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases
MX2010003019A (es) Celulas adherentes de los tejidos adiposo y de placenta y uso de las mismas en la terapia.
SI2625199T1 (en) Procedures for treating psoriasis using IL-17 antagonists
RU2015135843A (ru) Терапевтическое средство от грыжи межпозвоночного диска
EA201490911A1 (ru) Способы лечения злокачественных опухолей с использованием пероральных составов аналогов цитидина
BR112014027010A2 (pt) uso de laquinimod de alta dose para tratamento de esclerose múltipla
RU2014122858A (ru) Лечение когнитивных расстройств (r)-7-хлор-n-(хинуклидин-3-ил)бензо[в]тиофен-2-карбосамидом и его фармацевтически приемлемыми солями
Wen et al. Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome
JP2015532293A5 (ja) 糖尿病患者における心不全の治療用組成物
RU2012136724A (ru) Лечение или профилактика инфекции
WO2006022612A3 (en) Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
JP2013520447A5 (cg-RX-API-DMAC7.html)
RU2009101026A (ru) Применение тимозина-альфа-1 для получения лекарственного средства для лечения злокачественной меланомы на iv стадии
Millar et al. Frozen shoulder (Primer)
Ha et al. The efficacy and safety of a human perirenal adipose tissue-derived stromal vascular fraction in an interstitial cystitis rat model
EP4241788A3 (en) Methods of treating basal cell carcinoma and glioblastoma
RU2424008C1 (ru) Способ лечения ограниченной склеродермии
Huang et al. Prevention of Refractory Cough with Medialstinal Fat to Fill the Residual Cavity after Radical Systematic Mediastinal Lymphadenectomy in Patients with Right Lung Cancer